Open Access
- 28 June 2023
- journal article
- research article
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 20 (3) , 63-68
Abstract
Aim: To evaluate the prevalence of post-infection fatigue (PVFS) over one year after COVID-19. Material and methods: 165 people who had COVID-19 more than a year ago were interviewed. A Fatigue Assessment Scale was used to assess the degree of fatigue. Chemiluminescent analysis was carried out to detect antibodies to Epstein-Barr Virus (EBV) antigens. For statistical analysis Fisher's exact test and Spearman correlation were conducted. Results: Among people with PVFS, there were 4.1 times more women than men (80.4% vs. 19.6%), people over 45 years old (76%), and people who needed hospitalization for COVID-19 (76%). The average fatigue duration was 573±18,3 days. Among individuals without PVFS, there were significantly more individuals under the age of 45 compared with the group of individuals with PVFS (40% and 24%, respectively, p=0.007) and there were significantly more individuals who did not need hospitalization compared with the group of individuals with PVFS (52% vs. 24%, p=0.005). EBV reactivation was determined in almost half of the individuals with PVFS (48%), while none of the individuals without PVFS had EBV reactivation. A statistically significant negative mean correlation was found between the duration of PVFS and the severity of PVFS (r=-0.357, p=0.007). A statistically significant negative correlation was found between the PVFS duration and the PVFS severity (r=-0.357, p=0.007). Conclusion: PVFS is a prevalent symptom after COVID-19. The duration of PVFS can reach and not be limited to 1.5 years. PVFS is more typical of women, people over 45 years of age and people who have had moderate and severe COVID-19. Over time, the severity of PVFS decreases. Key words: COVID-19, post-infection fatigue, Epstein-Barr virusKeywords
This publication has 36 references indexed in Scilit:
- Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infectionPLOS ONE, 2020
- Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for EpidemiologyJournal of Clinical Medicine, 2020
- Differential diagnosis between “chronic fatigue” and “chronic fatigue syndrome”Integrative Medicine Research, 2019
- The Fatigue Assessment ScaleCurrent Opinion in Pulmonary Medicine, 2018
- Sarcoidosis-associated fatigueEuropean Respiratory Journal, 2012
- Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantationLeukemia, 2011
- Prevalence of Epstein-Barr Virus Reactivation in PregnancyAmerican Journal of Perinatology, 2010
- Assessment of fatigue among working people: a comparison of six questionnairesOccupational and Environmental Medicine, 2003
- Psychometric qualities of a brief self-rated fatigue measureJournal of Psychosomatic Research, 2003
- Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infectionAPMIS, 1996